94 related articles for article (PubMed ID: 3666863)
1. Antihypertensive effects of an aromatase inhibitor in the spontaneously hypertensive rat.
Melby JC; Holbrook M; Griffing GT; Johnston JO
Hypertension; 1987 Nov; 10(5):484-7. PubMed ID: 3666863
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive effects of an aromatase inhibitor in inbred salt-sensitive rats.
Griffing GT; Melby JC; Holbrook M; Johnston ON
Hypertension; 1991 Jun; 17(6 Pt 1):771-5. PubMed ID: 2045138
[TBL] [Abstract][Full Text] [Related]
3. Selective 19-hydroxylase inhibition by an aromatase inhibitor, 4-hydroxyandrostenedione.
Griffing GT; Holbrook M; Melby JC; Brodie AH
Clin Physiol Biochem; 1988; 6(3-4):171-8. PubMed ID: 3203487
[TBL] [Abstract][Full Text] [Related]
4. 19-Hydroxylase inhibition of adrenal mitochondrial P450 11 beta/18/19-hydroxylase by a suicide inhibitor.
Griffing GT; Holbrook M; Melby JC; Alberta J; Orme-Johnson NR
Am J Med Sci; 1989 Aug; 298(2):83-8. PubMed ID: 2788364
[TBL] [Abstract][Full Text] [Related]
5. 19-Nor-corticosteroids in health, in hypertensive states in humans including 17 alpha-hydroxylase deficiency and in the spontaneously hypertensive rat (SHR).
Melby JC; Dale SL; Holbrook M; Wilson TE; Griffing GT; Arison BH
Endocr Res; 1984-1985; 10(3-4):591-607. PubMed ID: 6336061
[TBL] [Abstract][Full Text] [Related]
6. The effect of gonadectomy and aromatase inhibition on the excretion of 19-nordeoxycorticosterone in rats.
Gomez-Sanchez EP; Gomez-Sanchez CE
J Steroid Biochem Mol Biol; 1991 Aug; 39(2):185-8. PubMed ID: 1888677
[TBL] [Abstract][Full Text] [Related]
7. Chronic administration of tiapamil prevents hemodynamic alterations accompanying development of high blood pressure in hypertensive rats.
Hefti F; Gerold M; Holck M
J Cardiovasc Pharmacol; 1984; 6(6):1192-200. PubMed ID: 6084779
[TBL] [Abstract][Full Text] [Related]
8. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
Schiffrin EL; Turgeon A; Deng LY
Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
[TBL] [Abstract][Full Text] [Related]
9. Deoxycorticosterone prevents the blood pressure-lowering effect of calcium in spontaneously hypertensive rats.
Wuorela H; Pörsti I; Siltaloppi E; Arvola P; Nurmi AK; Säynävälammi P; Vapaatalo H
Methods Find Exp Clin Pharmacol; 1990; 12(1):37-42. PubMed ID: 2156118
[TBL] [Abstract][Full Text] [Related]
10. Effects of calcium supplementation and deoxycorticosterone on plasma atrial natriuretic peptide and electrolyte excretion in spontaneously hypertensive rats.
Pörsti I; Wuorela H; Arvola P; Mämmi P; Nurmi AK; Koistinaho J; Laippala P; Vapaatalo H
Acta Physiol Scand; 1991 Mar; 141(3):343-50. PubMed ID: 1830445
[TBL] [Abstract][Full Text] [Related]
11. Parathyroidectomy significantly decreases hypertension in spontaneously hypertensive and deoxycorticosterone plus saline treated rats.
Gairard A; Berthelot A; Schleiffer R; Pernot F
Can J Physiol Pharmacol; 1982 Feb; 60(2):208-12. PubMed ID: 7083070
[TBL] [Abstract][Full Text] [Related]
12. 19-Hydroxyandrostenedione amplifies the hypertensive action of mineralocorticoids in rats.
Sekihara H; Yazaki Y; Kojima T
J Endocrinol; 1993 Jul; 138(1):31-40. PubMed ID: 7852890
[TBL] [Abstract][Full Text] [Related]
13. Mineralocorticoid treatment upregulates the hypothalamic vasopressinergic system of spontaneously hypertensive rats.
Pietranera L; Saravia F; Roig P; Lima A; De Nicola AF
Neuroendocrinology; 2004; 80(2):100-10. PubMed ID: 15475662
[TBL] [Abstract][Full Text] [Related]
14. The hypertensinogenic activity of 19-nor-deoxycorticosterone in the adrenalectomized spontaneously hypertensive rat.
Gorsline J; Morris DJ
J Steroid Biochem; 1985 Oct; 23(4):535-6. PubMed ID: 3906279
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats.
Schiffrin EL; Sventek P; Li JS; Turgeon A; Reudelhuber T
Br J Pharmacol; 1995 Aug; 115(8):1377-81. PubMed ID: 8564194
[TBL] [Abstract][Full Text] [Related]
16. Renal function contributes to antihypertensive effect of vasopressin in DOCA-salt but not spontaneous hypertension.
Wang H; McNeill JR
Am J Physiol; 1994 Nov; 267(5 Pt 2):H1842-50. PubMed ID: 7977814
[TBL] [Abstract][Full Text] [Related]
17. The effects of in vivo administration of 10-propargylestr-4-ene-3,17-dione on rat ovarian aromatase and estrogen levels.
Brandt ME; Covey DF; Zimniski SJ
J Enzyme Inhib; 1990; 4(2):143-52. PubMed ID: 2098521
[TBL] [Abstract][Full Text] [Related]
18. Role of adrenal steroidogenesis in etiology of hypertension in the spontaneously hypertensive rat.
Komanicky P; Reiss DL; Dale SL; Melby JC
Endocrinology; 1982 Jul; 111(1):219-24. PubMed ID: 7084111
[TBL] [Abstract][Full Text] [Related]
19. Long-lasting hypotensive and antihypertensive effects of a new 1,5-benzothiazepine calcium antagonist in hypertensive rats and renal hypertensive dogs.
Narita H; Murata S; Yabana H; Kikkawa K; Sugawara Y; Akimoto Y; Nagao T
Arzneimittelforschung; 1988 Apr; 38(4):515-20. PubMed ID: 3041970
[TBL] [Abstract][Full Text] [Related]
20. Effect of central administration of MK-422 (the diacid form of enalapril) on the development of hypertension in the spontaneously hypertensive rat.
Berecek KH; Nagahama S; Oparil S
J Hypertens Suppl; 1984 Dec; 2(3):S63-6. PubMed ID: 6100756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
